Statistics on Biotechnology Use  
Results by sector of operation
Total sectors. Biotechnology results by main variables and fields of operation. 
Unidades: specified in variables

,Total,Units,P.A.,Higher Education,PNPI,
Units that perform R+D in Biotechnology,1.256,1.056,123,66,11,
%Units according to biotechnology used: Genetic code,44,36,90,86,55,
%Units according to biotechnology used: Functional units,52,45,90,92,46,
%Units according to biotechnology used: Cellular and tissue culturing and engineering,35,27,76,80,73,
%Units according to biotechnology used: Bioprocesses,50,47,59,88,46,
%Units according to biotechnology used: Sub-cellular organisms,17,8,56,68,36,
%Units according to biotechnology used: Bio-computing,32,25,71,83,27,
%Units according to biotechnology used: Nanobiotechnology,20,13,50,73,9,
%Units according to biotechnology used: Other,14,15,9,14,9,
Units in which biotechnology activities are:  Main and/or exclusive,598,551,34,4,9,
Units in which biotechnology activities are: A secondary line of business,265,183,38,43,1,
Units in which biotechnology activities are: A tool necessary for production,394,323,51,19,1,
%Units by field(s) of ultimate application of biotechnology use: Human health,54,49,80,91,73,
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,22,20,16,62,9,
%Units by field(s) of ultimate application of biotechnology use: Food products,32,30,20,83,0,
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:,25,23,19,70,18,
%Units by field(s) of ultimate application of biotechnology use: Environment,17,13,24,71,9,
%Units by field(s) of ultimate application of biotechnology use: Industry,15,12,12,68,9,
Personnel in R&D in biotechnology (no. of persons),38.311,10.719,13.881,13.355,356,
Personnel in R&D in biotechnology (no. of persons): Researchers,25.082,6.131,8.130,10.534,287,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,13.229,4.588,5.751,2.821,69,
Personnel in R&D in biotechnology (no. of persons): women,21.567,6.040,8.575,6.734,218,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,13.264,3.411,4.624,5.057,172,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,8.303,2.629,3.951,1.677,46,
Personnel in R&D in biotechnology (FTE),26.692,1,7.750,8,10.337,9,8.497,2,106,2,
Personnel in R&D in biotechnology (FTE): Researchers,16.693,3,4.518,1,5.616,2,6.496,1,62,9,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,9.998,8,3.232,7,4.721,7,2.001,1,43,3,
Personnel in R&D in biotechnology (FTE): women,15.343,5,4.471,4,6.461,1,4.337,4,73,6,
Personnel in R&D in biotechnology (FTE): (women) Researchers,9.002,9,2.562,7,3.249,3,3.148,42,9,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,6.340,6,1.908,7,3.211,8,1.189,4,30,7,
Internal expenditure on R&D (thousands of euros),1.693.773,679.558,610.723,397.671,5.821,
1) By nature of the expense: Current expenses,1.585.388,634.631,574.604,370.428,5.723,
1.1) Remuneration to researchers,659.430,228.857,210.344,218.729,1.501,
1.2) Remuneration to technicians and assistants,278.456,104.498,118.726,54.188,1.044,
1.3) Other current expenses,647.501,301.276,245.535,97.512,3.178,
2) By nature of the expense: Capital expenses,108.386,44.927,36.118,27.243,98,
2.1) Land and buildings,13.514,2.585,5.020,5.909,0,
2.2) Equipment and instruments,73.707,23.569,30.028,20.012,98,
2.3) Acquisition of specific R+D software,3.621,1.392,992,1.237,0,
2.4) Otros productos de propiedad intelectual específicos para I+D,17.544,17.381,78,85,0,
1) By origin of the funds: National funds,1.456.745,556.297,546.727,348.357,5.365,
1.1) Own funds,597.793,387.010,135.388,74.853,541,
1.2) From companies,171.566,86.025,50.625,32.844,2.073,
1.3) Public Administration funds,638.127,74.764,329.591,232.956,816,
1.4) From Universities,2.780,408,1.808,535,29,
1.5) From non profit private institutions,46.480,8.090,29.315,7.170,1.906,
1) By origin of the funds: Foreign funds,237.028,123.262,63.996,49.314,456,
2.1) From EU programmes,119.838,25.125,52.212,42.501,0,
2.2) Other foreign funds,117.190,98.137,11.784,6.813,456,
Purchase of services R & D in Biotechnology to (thousands of euros),177.895,147.558,26.353,3.597,386,
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain,105.337,76.875,24.581,3.554,326,
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad,72.558,70.683,1.772,43,60,
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital,50,49,58,53,73,
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information,13,14,7,8,27,
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources,20,16,42,41,27,
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,15,13,27,30,18,
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,20,18,33,36,18,
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels,20,18,29,36,36,
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,16,17,9,11,18,
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,37,37,39,30,46,
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost,52,51,54,58,55,
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,18,18,20,14,27,
%Units that have requested biotechnology patents in Biotechnology,21,15,43,74,0,
Number of patents requested,1.770,746,539,485,0,
Notas:
'..'=data not available 

 '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent 

 (*) Total calculated from the total number of companies with related activities  with Biotechnology and the total units from other sectors with activities  in R&D in Biotechnology
Fuente: National Statistics Institute